TUCSON, Ariz.--(BUSINESS WIRE)--Before heart failure stopped him in his tracks, 45-year-old Troy Golden (photo) had preached every Sunday for the last 12 years at the New Life Assembly of God in Geary, Okla. Too sick to preach for the last six months, on Sunday, Nov. 21, Golden gave his first sermon since receiving the SynCardia temporary Total Artificial Heart and being discharged home using the Freedom® portable driver.
“The hope and faith and trust that I have, comes from a Lord who has given me new life,” said Golden. “It’s wonderful… I just can’t express how wonderful and awesome it has been to preach again.”
In the crowd at the rural Oklahoma church were Golden’s cardiovascular surgeon, Dr. James Long, and his heart failure cardiologist, Dr. Douglas Horstmanshof, both co-directors of the Advanced Cardiac Care program at INTEGRIS Baptist Medical Center.
Golden is participating in an FDA-approved Investigational Device Exemption (IDE) clinical study of the 13.5 lb Freedom driver, the first portable driver designed to power the SynCardia Total Artificial Heart both inside and outside the hospital. The IDE clinical study is designed to demonstrate that the Freedom driver is a suitable pneumatic driver for stable Total Artificial Heart patients and can be safely used at home.
“It boggles my mind that I was hooked up to a 418-pound machine, and here’s a little, 13-, 14-pound machine doing the same thing,” said Golden. “It’s unbelievable.”
Currently, the only FDA-approved driver for powering the Total Artificial Heart is the 418-pound "Big Blue" hospital driver. Patients are confined to the hospital while supported by Big Blue.
Golden was born with a genetic condition that has been slowly attacking his heart since birth. In January, he was put on the heart transplant list, but his condition continued to deteriorate. On Sept. 15, Golden became the first person in the region to receive the Total Artificial Heart. On Oct. 18, he became only the second Total Artificial Heart patient in U.S. history to be discharged from the hospital to wait for a matching donor heart at home.
While in the hospital, Golden wrote several sermons, most of which shared a common thread: “There is always hope,” said Golden. “No matter where you are at in your life, no matter what the circumstance, we have to keep the faith.”
About SynCardia Systems, Inc.
SynCardia Systems, Inc. is the Tucson-based manufacturer of the world’s only FDA, Health Canada and CE approved Total Artificial Heart: the SynCardia temporary Total Artificial Heart. There have been more than 850 implants of the Total Artificial Heart, accounting for more than 200 patient years of life on the device.
Originally used as a permanent replacement heart, the Total Artificial Heart is currently approved as a bridge to human heart transplant for people dying from end-stage biventricular failure. The Total Artificial Heart is the only device that provides immediate, safe blood flow of up to 9.5 L/min through both ventricles.
For additional information, please visit: http://www.syncardia.com
or follow SynCardia on Twitter – @SynCardia_News